<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref70">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Pu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Voronin</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2020</year>). 
  <article-title>Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine</article-title>. 
  <source>Cell. Mol. Immunol.</source>
  <volume>17</volume>, 
  <fpage>613</fpage>â€“
  <lpage>620</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41423-020-0400-4</pub-id>, PMID: 
  <?supplied-pmid 32203189?>
  <pub-id pub-id-type="pmid">32203189</pub-id>
 </mixed-citation>
</ref>
